Major Medical Groups Urge States to Use Juul Settlement for Anti-Smoking Programs

Sep.29.2022
Major Medical Groups Urge States to Use Juul Settlement for Anti-Smoking Programs
Health groups urge states to use $438.5 million Juul settlement for tobacco prevention programs, especially for youth.

Major medical organizations are urging the state, which won a $438.5 million settlement against e-cigarette manufacturer Juul Labs Inc. earlier this month, to use the money towards tobacco prevention and cessation programs, particularly for young people.


Selling electronic cigarette products to children is illegal in all 50 states. However, since Juul released its sweet-flavored electronic cigarettes in 2017, there has been an increase in teenage use of nicotine-containing products. States and school districts have launched various educational campaigns aimed at discouraging children from using harmful and addictive products.


On September 6th, a settlement agreement was reached that not only requires Juul to pay fees to each state over the course of 6-10 years, but also prohibits the company from conducting any further marketing campaigns targeting young people. The agreement also restricts the range of product sales and advertising, prohibits the use of unapproved flavors by the US Food and Drug Administration, and prohibits the marketing of free samples and branded goods.


In a letter dated September 27, the Campaign for Tobacco-Free Kids, the American Cancer Society Cancer Action Network, the American Heart Association, the American Lung Association, and Americans for Nonsmokers' Rights and Truth Initiative have called on states to "build on the historic 1998 Master Settlement Agreement (MSA) with the tobacco industry, while avoiding some of the mistakes that were made, to achieve further success.


These organizations cited a report from the Smoke-Free Kids campaign, which showed that only 2.7% of the $27 billion in tobacco settlements and taxes collected by states in the 2022 fiscal year were allocated towards programs aimed at preventing children from smoking and assisting smokers in quitting.


Connecticut Attorney General William Tong stated in his announcement of the proposed settlement, expected to be finalized in October, that JUUL's flippant advertising campaigns have created a new generation of nicotine addicts. "They shamelessly marketed their e-cigarette products to minors, manipulated their chemical makeup to make them palatable to inexperienced users, utilized inadequate age verification procedures, and misled consumers about the nicotine content and addictiveness of their products," Tong wrote.


In a statement, Juul has said that the settlement agreement is "an important component of our ongoing efforts to address past issues.


It further stated, "The terms of this agreement are consistent with our current business practices implemented company-wide after being reset in the fall of 2019.


According to data from the Centers for Disease Control and Prevention, over two million high school students reported using e-cigarettes in 2021, with eight out of ten students using flavored products.


In 2019, Governor Gretchen Whitmer made Michigan the first state to ban flavored e-cigarette products in an effort to reduce youth vaping. Other states have also issued similar orders, and all states have incorporated e-cigarettes into laws that restrict the sale of tobacco to minors. At least 18 states have raised the legal smoking age to 21.


In 2020, the FDA banned all nicotine products flavors except for menthol and tobacco.


During the announcement of the settlement agreement, several state attorneys general stated their intention to use the funds for smoking cessation and prevention programs. Health organizations urged all states in a letter to "translate this admirable intention into a strong commitment expressed in the final text of the agreement.


In 2020, the Attorneys General of Connecticut, Oregon, and Texas began investigating the company's marketing and sales practices, with 30 other states joining the effort: Alabama, Arkansas, Delaware, Georgia, Hawaii, Idaho, Indiana, Kansas, Kentucky, Maryland, Maine, Mississippi, Montana, North Dakota, Nebraska, New Hampshire, New Jersey, Nevada, Ohio, Oklahoma, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Virginia, Vermont, Wisconsin, and Wyoming.


Afterward, the state of Maine chose to withdraw from the settlement.


Statement:


This article is compiled from third-party information and is provided solely for industry professionals to exchange and learn from.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot verify the truth or accuracy of the article's content. The compilation of this article is only intended for industry-related exchange and research.


Due to limitations in our translation abilities, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


In regards to any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions, 2FIRSTS maintains complete alignment with the Chinese government.


The ownership of the copyright for the compiled information belongs to the original media and authors. If there is any infringement, please contact us for the information to be deleted.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05